Chairs: Paolo Pozzilli (IT/UK) and David Leslie (UK)
Pre diabetes, when is it worth treating it?
Mahmoud Ibrahim (USA)
Does a proper diagnosis of diabetes make a difference?
Sanjeevi Carani (Sweden)
Pathogenesis of type 1 and type 2 diabetes, what is the re-emerging role of Glucagon?
Agostino Consoli (Italy)
When should we be concerned that statins boost type 2 diabetes?
Peter Gaede (Denmark)
Metabolic syndrome and type 2 diabetes: which one comes first?
Christophe De Block (Belgium)